What is Immune Checkpoint Inhibitor Therapy?
Immune checkpoint inhibitor therapy blocks signals such as PD-1, PD-L1 or CTLA-4 that can restrain immune-cell activity against cancer. The drug is usually infused in day-care every two to six weeks, with schedules depending on medicine and indication. Combination regimens may have different visit calendars.
Read the complete Immune Checkpoint Inhibitor Therapy treatment guide





